Damora Therapeutics's total assets for Q1 2026 were $535.44M, an increase of 105.52% from the previous quarter. DMRA total liabilities were $25.18M for the fiscal quarter, a 24.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.